{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T06:44:14Z","timestamp":1788417854841,"version":"build-2803163510"},"reference-count":50,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100030845","name":"IRCCS Fondazione Stella Maris","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100030845","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ymgme.2026.109907","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T17:50:38Z","timestamp":1773942638000},"page":"109907","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Efficacy of JAK1\/2 inhibitors in AGS genes-related interferonopathies: A multicenter retrospective observational study with treated vs untreated comparison"],"prefix":"10.1016","volume":"148","author":[{"given":"Gemma","family":"Marinella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ylenia","family":"Vaia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Politano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Galli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Nicita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina Martinez","family":"Popple","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Pichiecchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Pasquariello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Parazzini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Pinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Longo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariasavina","family":"Severino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Fazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Orcesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Tonduti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Battini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Orsini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiammetta","family":"Zunica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Arrigoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Nicolosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Insalaco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Cattalini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duccio Maria","family":"Cordelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Soliani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Fetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca Felicia","family":"Operto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Amadori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Margherita","family":"Mancardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Volpi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia Maria","family":"Orsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.ymgme.2026.109907_bb0005","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nri3850","article-title":"Aicardi\u2013Gouti\u00e8res syndrome and the type I interferonopathies","volume":"15","author":"Crow","year":"2015","journal-title":"Nat. Rev. Immunol."},{"issue":"8","key":"10.1016\/j.ymgme.2026.109907_bb0010","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/ng1845","article-title":"Mutations in the gene encoding the 3\u2032-5\u2019 DNA exonuclease TREX1 cause Aicardi-Gouti\u00e8res syndrome at the AGS1 locus","volume":"38","author":"Crow","year":"2006","journal-title":"Nat. Genet."},{"issue":"8","key":"10.1016\/j.ymgme.2026.109907_bb0015","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1038\/ng1842","article-title":"Mutations in genes encoding ribonuclease H2 subunits cause Aicardi-Gouti\u00e8res syndrome and mimic congenital viral brain infection","volume":"38","author":"Crow","year":"2006","journal-title":"Nat. Genet."},{"issue":"06","key":"10.1016\/j.ymgme.2026.109907_bb0020","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1055\/s-0036-1592307","article-title":"Neurologic phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR1, and IFIH1: Aicardi\u2013Gouti\u00e8res syndrome and beyond","volume":"47","author":"Livingston","year":"2016","journal-title":"Neuropediatrics"},{"issue":"7","key":"10.1016\/j.ymgme.2026.109907_bb0025","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/ng.373","article-title":"Mutations involved in Aicardi-Gouti\u00e8res syndrome implicate SAMHD1 as regulator of the innate immune response","volume":"41","author":"Rice","year":"2009","journal-title":"Nat. Genet."},{"issue":"11","key":"10.1016\/j.ymgme.2026.109907_bb0030","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1038\/ng.2414","article-title":"Mutations in ADAR1 cause Aicardi-Gouti\u00e8res syndrome associated with a type I interferon signature","volume":"44","author":"Rice","year":"2012","journal-title":"Nat. Genet."},{"issue":"5","key":"10.1016\/j.ymgme.2026.109907_bb0035","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/ng.2933","article-title":"Gain-of-function mutations in IFIH1 cause a spectrum of human disease phenotypes associated with upregulated type I interferon signaling","volume":"46","author":"Rice","year":"2014","journal-title":"Nat. Genet."},{"issue":"12","key":"10.1016\/j.ymgme.2026.109907_bb0040","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1038\/s41588-020-00737-3","article-title":"cGAS-mediated induction of type I interferon due to inborn errors of histone pre-mRNA processing","volume":"52","author":"Uggenti","year":"2020","journal-title":"Nat. Genet."},{"issue":"2","key":"10.1016\/j.ymgme.2026.109907_bb0045","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/ajmg.a.36887","article-title":"Characterization of human disease phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, and IFIH1","volume":"167","author":"Crow","year":"2015","journal-title":"Am. J. Med. Gene. Pt. A"},{"issue":"1","key":"10.1016\/j.ymgme.2026.109907_bb0050","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1212\/WNL.0000000000002228","article-title":"Neuroradiologic patterns and novel imaging findings in Aicardi-Gouti\u00e8res syndrome","volume":"86","author":"La Piana","year":"2016","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.ymgme.2026.109907_bb0055","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1177\/0883073814562252","article-title":"Early-onset Aicardi-Gouti\u00e8res syndrome: magnetic resonance imaging (MRI) pattern recognition","volume":"30","author":"Vanderver","year":"2015","journal-title":"J. Child Neurol."},{"issue":"4","key":"10.1016\/j.ymgme.2026.109907_bb0060","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.ymgme.2019.02.006","article-title":"Spontaneous MRI improvement and absence of cerebral calcification in Aicardi-Gouti\u00e8res syndrome: diagnostic and disease-monitoring implications","volume":"126","author":"Tonduti","year":"2019","journal-title":"Mol. Genet. Metab."},{"issue":"4","key":"10.1016\/j.ymgme.2026.109907_bb0065","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.coph.2012.06.008","article-title":"Jakinibs: a new class of kinase inhibitors in cancer and autoimmune disease","volume":"12","author":"Kontzias","year":"2012","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.ymgme.2026.109907_bb0070","doi-asserted-by":"crossref","first-page":"ii111","DOI":"10.1136\/annrheumdis-2012-202576","article-title":"Janus kinase inhibitors in autoimmune diseases","volume":"72","author":"O\u2019Shea","year":"2013","journal-title":"Ann. Rheum. Dis."},{"issue":"4","key":"10.1016\/j.ymgme.2026.109907_bb0075","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/ni.3691","article-title":"Mechanisms and consequences of Jak\u2013STAT signaling in the immune system","volume":"18","author":"Villarino","year":"2017","journal-title":"Nat. Immunol."},{"issue":"6","key":"10.1016\/j.ymgme.2026.109907_bb0080","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1007\/s10875-023-01500-z","article-title":"JAK inhibition in Aicardi-Gouti\u00e8res syndrome: a monocentric multidisciplinary real-world approach study","volume":"43","author":"Fr\u00e9mond","year":"2023","journal-title":"J. Clin. Immunol."},{"issue":"12","key":"10.1016\/j.ymgme.2026.109907_bb0085","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2016-210565","article-title":"Response to: \u2018JAK inhibition in STING-associated interferonopathy\u2019 by Crow et al","volume":"75","author":"T\u00fcngler","year":"2016","journal-title":"Ann. Rheum. Dis."},{"issue":"6","key":"10.1016\/j.ymgme.2026.109907_bb0090","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1212\/WNL.0000000000004921","article-title":"An open-label trial of JAK 1\/2 blockade in progressive IFIH1 -associated neuroinflammation","volume":"90","author":"Kothur","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2026.109907_bb0095","doi-asserted-by":"crossref","DOI":"10.55563\/clinexprheumatol\/aa6drm","article-title":"Monogenic interferon mediated diseases: novel phenotype and genotype characteristics from Saudi population","author":"Al-Saleem","year":"2024","journal-title":"Clin. Exp. Rheumatol."},{"issue":"1","key":"10.1016\/j.ymgme.2026.109907_bb0100","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s13023-025-03675-7","article-title":"Tofacitinib treatment for psoriatic skin lesions associated with Aicardi-Gouti\u00e8res syndrome 7\/singleton-Merten syndrome 1","volume":"20","author":"Beerepoot","year":"2025","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2026.109907_bb0105","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2021.725868","article-title":"Case report: the JAK-inhibitor Ruxolitinib use in Aicardi-Goutieres syndrome due to ADAR1 mutation","volume":"9","author":"Cattalini","year":"2021","journal-title":"Front. Pediatr."},{"issue":"1","key":"10.1016\/j.ymgme.2026.109907_bb0110","doi-asserted-by":"crossref","DOI":"10.1186\/s12969-024-01036-5","article-title":"Aicardi-Gouti\u00e8res syndrome type 6: report of ADAR variant and clinical outcome after ruxolitinib treatment in the neonatal period","volume":"22","author":"Gabaldon-Albero","year":"2024","journal-title":"Pediatr. Rheumatol."},{"issue":"8","key":"10.1016\/j.ymgme.2026.109907_bb0115","doi-asserted-by":"crossref","DOI":"10.1002\/ccr3.7724","article-title":"Treatment response to Janus kinase inhibitor in a child affected by Aicardi-Gouti\u00e8res syndrome","volume":"11","author":"Galli","year":"2023","journal-title":"Clin. Case Reports"},{"issue":"12","key":"10.1016\/j.ymgme.2026.109907_bb0120","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.3899\/jrheum.2024-0294","article-title":"Children with type I Interferonopathy: commonalities and diversities in a large patient cohort","volume":"51","author":"Haslak","year":"2024","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.ymgme.2026.109907_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmg.2025.105006","article-title":"Short-term efficacy of tofacitinib, a JAK inhibitor, in IFIH1-related Aicardi-Gouti\u00e8res syndrome","volume":"75","author":"Hou","year":"2025","journal-title":"Eur. J. Med. Genet."},{"issue":"3","key":"10.1016\/j.ymgme.2026.109907_bb0130","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s10875-024-01672-2","article-title":"Neuropathologic impacts of JAK inhibitor treatment in Aicardi-Gouti\u00e8res syndrome","volume":"44","author":"Jafarpour","year":"2024","journal-title":"J. Clin. Immunol."},{"issue":"2","key":"10.1016\/j.ymgme.2026.109907_bb0135","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.braindev.2021.10.001","article-title":"Autosomal dominant ADAR c.3019G>A (p.(G1007R)) variant is an important mimic of hereditary spastic paraplegia and cerebral palsy","volume":"44","author":"Jones","year":"2022","journal-title":"Brain Dev."},{"issue":"1","key":"10.1016\/j.ymgme.2026.109907_bb0140","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12969-023-00817-8","article-title":"Efficacy and safety of baricitinib in Japanese patients with autoinflammatory type I interferonopathies (NNS\/CANDLE, SAVI, and AGS)","volume":"21","author":"Kanazawa","year":"2023","journal-title":"Pediatr. Rheumatol."},{"issue":"9","key":"10.1016\/j.ymgme.2026.109907_bb0145","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1212\/WNL.0000000000200952","article-title":"Child neurology: Aicardi-Gouti\u00e8res syndrome presenting as recurrent ischemic stroke","volume":"99","author":"Kuang","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2026.109907_bb0150","article-title":"Janus kinase inhibitors in the treatment of type I Interferonopathies: a case series from a single center in China","volume":"13","author":"Li","year":"2022","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.ymgme.2026.109907_bb0155","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/art.40805","article-title":"Efficacy of Baricitinib in the treatment of chilblains associated with Aicardi-Gouti\u00e8res syndrome, a type I Interferonopathy","volume":"71","author":"Meesilpavikkai","year":"2019","journal-title":"Arthritis Rheumatol."},{"issue":"1","key":"10.1016\/j.ymgme.2026.109907_bb0160","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/14728214.2024.2445508","article-title":"Exploring emerging JAK inhibitors in the treatment of Aicardi\u2013Gouti\u00e8res syndrome","volume":"30","author":"Politano","year":"2025","journal-title":"Expert Opin. Emerg. Drugs"},{"issue":"5","key":"10.1016\/j.ymgme.2026.109907_bb0165","article-title":"TREX-1 related Aicardi-Gouti\u00e8res syndrome improved by Janus kinase inhibitor","volume":"194","author":"Ryckmans","year":"2024","journal-title":"Am. J. Med. Gene. Pt. A"},{"issue":"7","key":"10.1016\/j.ymgme.2026.109907_bb0170","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1172\/JCI98814","article-title":"JAK1\/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies","volume":"128","author":"Sanchez","year":"2018","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.ymgme.2026.109907_bb0175","article-title":"Baricitinib treatment in RNU7\u20131-associated Aicardi\u2013Gouti\u00e8res syndrome in a South African child: a case report","volume":"197","author":"Spracklen","year":"2025","journal-title":"Am. J. Med. Genet. Pt. A"},{"issue":"2","key":"10.1016\/j.ymgme.2026.109907_bb0180","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1007\/s00415-023-12040-2","article-title":"Rapidly progressive moyamoya vasculopathy stabilized with immunotherapy in aicardi-gouti\u00e8res syndrome","volume":"271","author":"Vancura","year":"2024","journal-title":"J. Neurol."},{"issue":"3","key":"10.1016\/j.ymgme.2026.109907_bb0185","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1080\/25785826.2025.2479148","article-title":"Overlapping Aicardi\u2013Gouti\u00e8res and Singleton\u2013Merten syndromes with a heterozygous gain-of-function mutation in IFIH1 mimicking juvenile idiopathic arthritis","volume":"48","author":"Yamazaki","year":"2025","journal-title":"Immunol. Med."},{"key":"10.1016\/j.ymgme.2026.109907_bb0190","article-title":"Case report: pneumocystis jirovecii pneumonia in a severe case of Aicardi-Gouti\u00e8res syndrome with an IFIH1 gain-of-function mutation mimicking combined immunodeficiency","volume":"13","author":"\u017deleznik","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymgme.2026.109907_bb0195","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.00985","article-title":"Interstitial lung disease and psoriasis in a child with Aicardi-Gouti\u00e8res syndrome","volume":"11","author":"Zheng","year":"2020","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.ymgme.2026.109907_bb0200","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s40264-025-01535-8","article-title":"Major adverse cardiovascular events related to JAK inhibitors: a disproportionality analysis using the WHO global individual case safety database","volume":"48","author":"Di Napoli","year":"2025","journal-title":"Drug Saf."},{"issue":"1","key":"10.1016\/j.ymgme.2026.109907_bb0205","doi-asserted-by":"crossref","first-page":"7140","DOI":"10.1038\/s41598-022-10777-w","article-title":"Adverse events associated with JAK inhibitors in 126,815 reports from the WHO pharmacovigilance database","volume":"12","author":"Hoisnard","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymgme.2026.109907_bb0210","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/bmb\/ldn049","article-title":"Aicardi-Gouti\u00e8res syndrome","volume":"89","author":"Orcesi","year":"2009","journal-title":"Br. Med. Bull."},{"issue":"1","key":"10.1016\/j.ymgme.2026.109907_bb0215","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-018-0854-y","article-title":"Encephalopathies with intracranial calcification in children: clinical and genetic characterization","volume":"13","author":"Tonduti","year":"2018","journal-title":"Orphanet J. Rare Dis."},{"issue":"2","key":"10.1016\/j.ymgme.2026.109907_bb0220","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ymgme.2020.03.008","article-title":"Development of a neurologic severity scale for Aicardi Gouti\u00e8res syndrome","volume":"130","author":"Adang","year":"2020","journal-title":"Mol. Genet. Metab."},{"issue":"5","key":"10.1016\/j.ymgme.2026.109907_bb0225","first-page":"289","article-title":"Mutations in the TREX1 gene and Aicardi\u2013Gouti\u00e8res syndrome","volume":"51","author":"Livingston","year":"2014","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.ymgme.2026.109907_bb0230","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ejpn.2022.10.003","article-title":"Identification of PMD subgroups using a myelination score for PMD","volume":"41","author":"Harting","year":"2022","journal-title":"Eur. J. Paediatr. Neurol."},{"issue":"9","key":"10.1016\/j.ymgme.2026.109907_bb0235","first-page":"1761","article-title":"Adrenoleukodystrophy: a scoring method for brain MR observations","volume":"15","author":"Loes","year":"1994","journal-title":"AJNR Am. J. Neuroradiol."},{"issue":"03","key":"10.1016\/j.ymgme.2026.109907_bb0240","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1055\/s-0037-1599141","article-title":"4H Leukodystrophy: a brain magnetic resonance imaging scoring system","volume":"48","author":"Vrij-van Den Bos","year":"2017","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.ymgme.2026.109907_bb0245","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1549183","article-title":"Pharmacological evaluation of drug therapies in Aicardi-Gouti\u00e8res syndrome: insights from patient-derived neural stem cells","volume":"16","author":"Braidotti","year":"2025","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.ymgme.2026.109907_bb0250","doi-asserted-by":"crossref","DOI":"10.1111\/sji.13314","article-title":"Aicardi\u2013gouti\u00e8res syndrome: a monogenic type I interferonopathy","volume":"98","author":"Liu","year":"2023","journal-title":"Scand. J. Immunol."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719226001903?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719226001903?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:58:37Z","timestamp":1787669917000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719226001903"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S1096719226001903"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2026.109907","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of JAK1\/2 inhibitors in AGS genes-related interferonopathies: A multicenter retrospective observational study with treated vs untreated comparison","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2026.109907","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109907"}}